الابحاث

South Egypt Cancer Institute

Assiut University

Department of Medical Oncology
# Title Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
32 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
33 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
34 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		Dr. Mayada Fawzy Sedik Farghaly 2021
35 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
36 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
37 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Dr. Mayada Fawzy Sedik Farghaly 2021
38 The role of quantitative computed tomography perfusion in the assessment of colorectal thickening Dr. Adel Gomaa Mohamed Gabr 2021
39 Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma Dr. Maged Abdelfatah Amine Hassan 2021
40 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Dr. Ahmed Refaat Abdel Zaher Mubarak 2021